Alarm.com Announces Proposed Private Placement of $375.0 Million of Convertible Senior Notes
TYSONS, Va.–(BUSINESS WIRE)–Alarm.com Holdings, Inc. (Nasdaq: ALRM) (“Alarm.com”), the leading platform for the intelligently connected property,... Read more.
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
– Collaboration utilizes Cartography’s ATLAS and SUMMIT Platforms to discover targets in triple-negative breast cancer and lung adenocarcinoma – – Cartography... Read more.
Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies
Expands Nordson MEDICAL’s total addressable market Highly complementary with Nordson’s customer base and core competencies Broadens Nordson’s exposure to higher-growth... Read more.
AtlasClear Holdings, Inc. Announces First Quarter 2024 Financial Results
TAMPA, Fla.–(BUSINESS WIRE)–AtlasClear Holdings, Inc. (“AtlasClear Holdings” or “AtlasClear”) (NYSE American: ATCH) announced that their financial... Read more.
Septerna to Participate in the Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Septerna, a biotechnology company discovering and advancing novel, oral small molecule medicines targeting... Read more.
Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
TOKYO & NEW YORK & DÜSSELDORF, Germany–(BUSINESS WIRE)–Asahi Kasei Corp. (TOKYO:3407) today announces that it will offer the shareholders of... Read more.
Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner
ALL-REMOTE COMPANY/WILMINGTON, Del.–(BUSINESS WIRE)–Phreesia, a leader in patient intake, outreach, and activation, has joined the MEDITECH Alliance... Read more.
NEXT Golf Tour Champion Jordan Weber Tees It Up on DP World Tour
38-year-old American makes his first top-level tour start at the European Open on Thursday, May 30 HAMBURG, Germany–(BUSINESS WIRE)–Jordan Weber’s... Read more.
Spire Global to Join Russell 3000® Index
VIENNA, Va.–(BUSINESS WIRE)–$SPIR—Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of space-based data, analytics... Read more.
Merck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival (OS) Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer (TNBC)
KEYTRUDA® (pembrolizumab) is the first and only immunotherapy-based regimen to show a statistically significant improvement in OS as pre-operative (neoadjuvant)... Read more.